A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD)

Mupfudze, TG; Preussler, JM; Sees, JA; SanCartier, M; Arnold, SD; Devine, S

Mupfudze, TG (corresponding author), Natl Marrow Donor Program Be Match, 500 N 5th St, Minneapolis, MN 55401 USA.

TRANSPLANTATION AND CELLULAR THERAPY, 2021; 27 (4): 345

Abstract

Sickle cell disease (SCD) is the most common inherited hemoglobin disorder, affecting approximately 100,000 people in the United States. Allogeneic he......

Full Text Link